[The prevention of DVT after general surgical interventions for cancer pathology].
The efficacy of postoperative DVT prophylaxis of defibrotide and heparin calcium was evaluated in a group of 47 patients undergoing general surgery for oncological pathologies. A sub-group (24 patients) received defibrotide treatment, 400 mg b.i.d. i.m.; the second subgroup (23 patients) was treated with heparin calcium, 5000 IU b.i.d. s.c., from the day before operation until the 7th postoperative day. No postoperative thrombotic symptoms were observed in either group of patients.
Barbieri
U
U
Servizio di Ematologia, Università degli Studi di Modena.
Righi
A
A
Amorotti
C
C
Di Prisco
U
U
Scorrano
M
M
Casolo
P
P
Zaniol
P
P
Gerosa
C
C
D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000601:surgery*; D011089:Polydeoxyribonucleotides / Q000008:administration & dosage; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D013924:Thrombophlebitis / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C006871:calcium heparin; C036901:defibrotide; D006493:Heparin
Profilassi delle TVP dopo interventi di chirurgia generale per patologie oncologiche.